Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017090719) CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/090719 International Application No.: PCT/JP2016/084944
Publication Date: 01.06.2017 International Filing Date: 25.11.2016
IPC:
C07D 471/04 (2006.01) ,A61K 31/519 (2006.01) ,A61K 31/55 (2006.01) ,A61P 35/00 (2006.01) ,A61P 43/00 (2006.01) ,C07D 519/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
471
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
55
having seven-membered rings, e.g. azelastine, pentylenetetrazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43
Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
519
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/ or C07D455/257
Applicants:
大鵬薬品工業株式会社 TAIHO PHARMACEUTICAL CO., LTD. [JP/JP]; 東京都千代田区神田錦町1-27 1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 1018444, JP
Inventors:
南口 和久 MINAMIGUCHI, Kazuhisa; JP
岡嶋 茂雄 OKAJIMA, Shigeo; JP
浅井 隆宏 ASAI, Takahiro; JP
浅井 雅則 ASAI, Masanori; JP
荻野 悦夫 OGINO, Yoshio; JP
Agent:
特許業務法人アルガ特許事務所 THE PATENT CORPORATE BODY ARUGA PATENT OFFICE; 東京都中央区日本橋人形町1丁目3番8号 沢の鶴人形町ビル Sawanotsuru Ningyocho Bldg., 1-3-8, Nihonbashi Ningyocho, Chuo-ku, Tokyo 1030013, JP
Priority Data:
2015-23227327.11.2015JP
Title (EN) CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF
(FR) COMPOSÉ PYRIMIDINE CONDENSÉ OU SEL DE CELUI-CI
(JA) 縮環ピリミジン化合物又はその塩
Abstract:
(EN) Provided is a compound having an inhibitory effect on androgen receptors. A condensed pyrimidine compound represented by general formula (I) or a pharmacologically acceptable salt thereof (in the formula, X, Y, Z, R1, and R2 are as defined in the specification).
(FR) Composé ayant un effet inhibiteur sur les récepteurs d'androgènes. L'invention concerne un composé pyrimidine condensé représenté par la formule générale (I) ou un sel pharmaceutiquement acceptable de celui-ci (dans ladite formule, X, Y, Z, R1, et R2 sont tels que définis dans la description).
(JA) アンドロゲン受容体に対して阻害作用を有する化合物の提供。下記一般式(I)で表される縮環ピリミジン化合物又はその薬学的に許容される塩(式中、X、Y、Z、R1、及びR2は明細書で定義した通りである)。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)
Also published as:
JPWO2017090719CN108431001EP3381916US20180312505